Brief: Tetra Bio-Pharma Signs Definitive Commercialization Agreement For Caumz In Mexico With Alternavida S.A.
Dec 2 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA SIGNS DEFINITIVE COMMERCIALIZATION
AGREEMENT
FOR CAUMZ™ IN MEXICO WITH ALTERNAVIDA S.A.
* TETRA BIO PHARMA - ALTERNAVIDA TO LAUNCH AND FUND 2
CLINICAL
SITES IN MEXICO AS PART OF CLINICAL RESEARCH COLLABORATION IN
COMMERCIALIZATION AGREEMENT
* TETRA - COLLABORATION POTENTIALLY ALLOWS CO TO ACCELERATE
PHASE
3 (SERENITY), PHASE 2 (FIBROMYALGIA) ENROLLMENTS WITH PROJECTED
COST SAVINGS OF CAD$10 MILLION
Source text for Eikon: ID:nGNX8fvGJW
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding